Literature DB >> 21173745

Obesity accompanies narcolepsy with cataplexy but not narcolepsy without cataplexy.

Karel Sonka1, David Kemlink, Jitka Busková, Martin Pretl, Zuzana Srůtková, Eszter Maurovich Horvat, Pavel Vodicka, Veronika Poláková, Sona Nevsímalová.   

Abstract

BACKGROUND: Narcolepsy with cataplexy (NC) differs from narcolepsy without cataplexy (NwoC) in the cerebrospinal fluid levels of hypocretin. Since hypocretin is known to regulate not only wakefulness but also eating behaviour, we decided to compare the two entities for body mass index (BMI) and the presence of obesity.
METHODS: Clinical data on patients with NC and NwoC was studied and examined, including nocturnal polysomnography and the Multiple Sleep Latency Test (MSLT). The results were rated against a group of age- and sex-matched healthy controls.
RESULTS: The BMI in NC (29.1±SD=5.8) was significantly higher than in NwoC (25.4±4.4) or in the controls (25.8±3.9) (p<0.001, F=17.4, df= 323), while no difference in BMI was found between NwoC and the controls. The proportion of patients with BMI >30 was significantly greater in NC (39.0%) than in NwoC (13.8%) or than in the control group (13.0%). A negative correlation of BMI and sleep latency in MSLT (p=0.009) was found in the combined NC and NwoC groups.
CONCLUSION: Unlike NC, NwoC has neither a higher BMI nor a higher incidence of obesity than the general population.

Entities:  

Mesh:

Year:  2010        PMID: 21173745

Source DB:  PubMed          Journal:  Neuro Endocrinol Lett        ISSN: 0172-780X            Impact factor:   0.765


  11 in total

1.  Diagnosis and management of central hypersomnias.

Authors:  Karel Sonka; Marek Susta
Journal:  Ther Adv Neurol Disord       Date:  2012-09       Impact factor: 6.570

2.  The Humanistic and Economic Burden of Narcolepsy.

Authors:  Natalia M Flores; Kathleen F Villa; Jed Black; Ronald D Chervin; Edward A Witt
Journal:  J Clin Sleep Med       Date:  2016-03       Impact factor: 4.062

Review 3.  Central Disorders of Hypersomnolence: Focus on the Narcolepsies and Idiopathic Hypersomnia.

Authors:  Zeeshan Khan; Lynn Marie Trotti
Journal:  Chest       Date:  2015-07       Impact factor: 9.410

4.  Morbidities in rapid eye movement sleep behavior disorder.

Authors:  Poul Jennum; Geert Mayer; Yo-El Ju; Ron Postuma
Journal:  Sleep Med       Date:  2013-01-29       Impact factor: 3.492

5.  Comorbidity and mortality of narcolepsy: a controlled retro- and prospective national study.

Authors:  Poul Jennum; Rikke Ibsen; Stine Knudsen; Jakob Kjellberg
Journal:  Sleep       Date:  2013-06-01       Impact factor: 5.849

Review 6.  Etiopathogenesis and neurobiology of narcolepsy: a review.

Authors:  Swarup Kumar; Haritha Sagili
Journal:  J Clin Diagn Res       Date:  2013-12-27

Review 7.  Narcolepsy: neural mechanisms of sleepiness and cataplexy.

Authors:  Christian R Burgess; Thomas E Scammell
Journal:  J Neurosci       Date:  2012-09-05       Impact factor: 6.167

Review 8.  Pharmacological management of narcolepsy and cataplexy in pediatric patients.

Authors:  Michel Lecendreux
Journal:  Paediatr Drugs       Date:  2014-10       Impact factor: 3.022

9.  Delayed diagnosis, range of severity, and multiple sleep comorbidities: a clinical and polysomnographic analysis of 100 patients of the innsbruck narcolepsy cohort.

Authors:  Birgit Frauscher; Laura Ehrmann; Thomas Mitterling; David Gabelia; Viola Gschliesser; Elisabeth Brandauer; Werner Poewe; Birgit Högl
Journal:  J Clin Sleep Med       Date:  2013-08-15       Impact factor: 4.062

10.  Incidence and duration of common early-onset adverse events in randomized controlled trials of solriamfetol for treatment of excessive daytime sleepiness in obstructive sleep apnea and narcolepsy.

Authors:  Russell Rosenberg; Michael J Thorpy; Yves Dauvilliers; Paula K Schweitzer; Gary Zammit; Mark Gotfried; Shay Bujanover; Brian Scheckner; Atul Malhotra
Journal:  J Clin Sleep Med       Date:  2022-01-01       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.